A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes
Clinical trial NCT02773381 · COMPLETED
Trial details
- NCT number
- NCT02773381
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-02
- Primary completion
- 2018-10-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.